Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rusagro's revenues in the 1st half of the year increased by 30%

7/22/24 AGRO

Moscow Exchange launched its first Pre-IPO

7/19/24 MOEX

SR Space has started collecting applications for Pre-IPO participation

7/19/24 OTCI

Lenenergo purchases charging stations

7/19/24 LSNG

Rostelecom consolidated 100% of BFT-Holding

7/19/24 RTKM

Rosdorbank's additional issue is placed at the lower limit

7/18/24 RDRB

Cherkizovo reports for 6 months of 2024 by RAS

7/18/24 GCHE

Nornickel is negotiating the construction of a nickel plant in China

7/18/24 GMKN

X5 Retail Group launched parcel delivery

7/18/24 X5

VSMPO-AVISMA reported for 6 months of 2024 by RAS

7/18/24 VSMO